1

INTRODUCTION

One of the most damaging myths in obesity medicine is the idea that using GLP1 medications — like Wegovy, Zepbound, or Saxenda — is “cheating.”

Patients hear:

• “You should just eat less.”
• “You’re taking the easy way out.”
• “You don’t really want it if you need medication.”

These statements are not only wrong — they’re harmful.
They shame patients for using evidencebased medical treatment for a real metabolic disease.

GLP1 medications are not shortcuts.
They are not crutches.
They are not signs of weakness.

They are legitimate, sciencebased therapy for a chronic, relapsing, progressive disease that cannot be treated with willpower alone.

Let’s break down why.

‍

1. Obesity Is a Metabolic Disease — Not a Willpower Problem

Obesity is driven by:

• Hormones
• Genetics
• Gutbrain signaling
• Insulin resistance
• Inflammation
• Setpoint dysregulation

Not motivation.
Not discipline.
Not character.

GLP1 medications treat the biology of obesity — the same way insulin treats diabetes or inhalers treat asthma.

No one calls insulin “cheating.”
No one calls bloodpressure medication “the easy way out.”

Obesity deserves the same respect.

‍

2. GLP1s Restore a Hormonal Signal That Is Broken in Obesity

GLP1 is a hormone your gut naturally releases after eating.

It tells your brain:

• “I’m full.”
• “Stop eating.”
• “Slow digestion.”
• “Lower blood sugar.”

People with obesity often have blunted GLP1 responses, meaning:

• They don’t feel full as quickly
• They stay hungry longer
• They crave more
• They have stronger food reward pathways

GLP1 medications restore this signal.

This is not cheating.
This is fixing a broken pathway.

‍

3. GLP1s Lower the Body’s Defended Weight (SetPoint)

Your body has a “setpoint” — the weight it defends.

When you lose weight:

• Hunger increases
• Metabolism slows
• Cravings intensify
• Fat storage becomes more efficient

This is why dieting alone fails for most people.

GLP1 medications lower the setpoint, meaning:

• Your body stops fighting weight loss
• Hunger decreases
• Cravings fade
• Weight becomes easier to maintain

This is not cheating.
This is treating the root cause.

‍

4. GLP1s Improve Insulin Sensitivity and Reduce Inflammation

Obesity is tightly linked to:

• Insulin resistance
• High insulin levels
• Chronic inflammation
• Fatty liver disease

GLP1 medications:

• Improve insulin sensitivity
• Lower fasting insulin
• Reduce inflammation
• Improve liver fat
• Stabilize blood sugar

These are medical effects, not psychological ones.

‍

5. GLP1s Reduce Hunger and Cravings — They Don’t Replace Healthy Habits

Patients still need to:

• Choose nutritious foods
• Prioritize protein
• Stay hydrated
• Move their bodies
• Build longterm habits

GLP1s simply make these behaviors possible.

Patients often say:

• “This is the first time I’ve felt in control.”
• “I can finally stop eating when I’m full.”
• “Food doesn’t dominate my thoughts anymore.”

That’s not cheating.
That’s normal physiology restored.

‍

6. GLP1s Are Not Easy — They Require Commitment

These medications require:

• Medical evaluation
• Dose titration
• Monitoring
• Managing side effects
• Nutrition adjustments
• Longterm followup

Patients work hard.
They show up.
They stay engaged.

Nothing about this is “easy.”

‍

7. GLP1s Are Not Cosmetic — They Improve Health

GLP1 medications improve:

• Blood sugar
• Blood pressure
• Cholesterol
• Liver fat
• Inflammation
• Sleep apnea
• Joint pain
• Cardiovascular risk

They reduce the risk of:

• Heart attack
• Stroke
• Kidney disease
• Diabetes progression

This is medical therapy, not vanity.

‍

8. GLP1s Are Not a Replacement for Bariatric Surgery — They Are a Complement

For some patients, GLP1s are enough.
For others, they are a bridge to surgery.
For many, they are a longterm metabolic support tool after surgery.

They are part of a comprehensive treatment plan, not a standalone cure.

‍

9. The Most Important Message: You Deserve Real Treatment

If you’re using GLP1 medication, here’s what I want you to know:

You are not cheating.
You are not weak.
You are not taking the easy way out.
You are treating a real disease with real medicine.

You deserve the same respect as any patient managing a chronic condition.

GLP1s give patients their lives back — not because they replace effort, but because they make effort finally work.

‍

CONCLUSION

GLP1 medications are one of the most important breakthroughs in obesity medicine.
They treat the biology of the disease — not the behavior.

They:

• Reduce hunger
• Reduce cravings
• Improve insulin sensitivity
• Lower the setpoint
• Improve metabolic health
• Support longterm success

Using them is not cheating.
It is evidencebased medical care for a chronic disease that deserves real treatment, real compassion, and real solutions.